01244.HK
3D Medicines Inc.
HKSE · Healthcare · Biotechnology · CN
HKD 2.61
+3.98%Margins
Gross margin
88.5%
EBITDA margin
-46.6%
EBIT margin
-22.6%
Net margin
-48.5%
FCF margin
-48.9%
-33.1%
Return on equity
-18.5%
Return on assets
-11.6%
Return on invested capital
0.38x
Asset turnover
-HKD 205.5M
Cash from operations
HKD 1.89
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026